A study reveals that venetoclax consolidation after BTKi therapy is effective for chronic lymphocytic leukemia, offering ...

Zhuo, C., et al. (2025). Single-cell sequencing reveals the expansion and diversity of T cell subsets in the bone marrow ...

At a lymphoma conference, experts sparred about treatment options, while an outside expert highlighted the value of each approach.

The research looked specifically at blood stem cells, which live in the bone marrow and make different types of blood cells.

Two veteran biotech investors have reunited to form a new venture capital firm focusing on autoimmune diseases. Steven St. | ...

T-cell acute lymphoblastic leukemia (T-ALL) is a highly aggressive form of blood cancer that can occur in both children and ...

Planned cesarean linked to higher risk of childhood acute lymphoblastic leukemia B-cell acute lymphoblastic leukemia risk ...

A joint project led by Professors Liran Shlush and Amos Tanay could fundamentally change the means of diagnosis and treatment ...

Vie Ventures, a new life sciences investment firm focused on bridging venture capital and disease philanthropy to develop breakthrough therapies for patients, today announced its official launch. Vie ...

Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...

The program expired last year as a cost cutting measure. Though renewed, some still have qualms with the program.